Christopher E Grant

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Advanced Non Small Cell Lung Cancer

Top Venues

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher E Grant, Amy L Flis, Leila Toulabi, Adriana Zingone, Emily Rossi, Krist Aploks, Heather Sheppard, Bríd M Ryan
DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC. Molecular oncology 18 (6) (2024)
Christopher E Grant, Amy L Flis, Leila Toulabi, Adriana Zingone, Emily Rossi, Krist Aploks, Heather Sheppard, Bríd M Ryan
DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC. Molecular oncology 18 (6) (2024)
Christopher E Grant, Amy L Flis, Leila Toulabi, Adriana Zingone, Emily Rossi, Krist Aploks, Heather Sheppard, Bríd M Ryan
DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC. Molecular oncology 18 (6) (2024)
Christopher E Grant, Amy L Flis, Leila Toulabi, Adriana Zingone, Emily Rossi, Krist Aploks, Heather Sheppard, Bríd M Ryan
DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC. Molecular oncology 18 (6) (2024)
Christopher E Grant, Amy L Flis, Leila Toulabi, Adriana Zingone, Emily Rossi, Krist Aploks, Heather Sheppard, Bríd M Ryan
DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC. Molecular oncology (2024)
Christopher E Grant, Amy L Flis, Bríd M Ryan
Understanding the role of dopamine in cancer: past, present and future. Carcinogenesis 43 (6) (2022)